Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia

American Journal of Pathology

Volumn 158, Issue 2, 2001, Pages 515-526

  Holton, Janice L ^a   Ghiso, Jorge ^e   Lashley, Tammaryn ^a   Rostagno, Agueda ^e   Guerin, Christopher J ^c   Gibb, Graham ^d   Houlden, Henry ^a   Ayling, Hilary ^a   Martinian, Lillian ^a   Anderton, Brian H ^d   Wood, Nicholas W ^a   Vidal, Ruben ^e   Plant, Gordon ^b   Frangione, Blas ^e   Revesz, Tamas ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c MRC TOXICOLOGY UNIT   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID PRECURSOR PROTEIN; DIRECT YELLOW 7; TAU PROTEIN; THIOFLAVINE; UNCLASSIFIED DRUG;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DEGENERATIVE DISEASE; FAMILIAL BRITISH DEMENTIA; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LIMBIC CORTEX; MACROGLIA; MICROGLIA; NEUROFIBRILLARY TANGLE; NEUROPIL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; VASCULAR AMYLOIDOSIS;

EID: 0035137042     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63993-4     Document Type: Article

References (44)

1. Familial presenile dementia with spastic paralysis
2. Familial cerebral amytoid angiopathy with nonneuritic amyloid plaque formation
3. Familial British dementia with amyloid anglopathy: Early clinical, neuropsychological and imaging findings
4. A form of familial presenile dementia with spastic paralysis (including the pathological examination of a case)
5. Cytoskeletal pathology in familial cerebral amyloid angiopathy (British type) with non-neuritic amyloid plaque formation
6. A stop-codon mutation in the BRI gene associated with familial British dementia
7. A decamer duplication in the 3′ region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred
8. The consortium to establish a registry for Alzheimer's disease (CERAD). 2. Standardization of the neuropathologic assessment of Alzheimer's disease
9. Neurofilament monoclonal antibodies RT97 and 8D8 recognize different modified epitopes in paired helical filament-tau in Alzheimer's disease
10. Tau in Alzheimer's disease and Down's syndrome is insoluble and abnormally phosphorylated
11. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
12. Alzheimer's neurofibrillary tangles are penetrated by astroglial processes and appear eosinophilic in their final stages
13. Immunohistochemical staging of neurofibrillary degeneration in Alzheimer's disease
14. On areas of transition between entorhinal allocortex and temporal isocortex in the human-brain: Normal morphology and lamina-specific pathology in Alzheimer's disease
15. Image analysis of GFA-positive astrocytes from adolescence to senescence
16. Alzheimer patients and Down patients: Cerebral preamyloid deposits differ ultrastructurally and histochemically from the amyloid of senile plaques
17. Prion protein preamyloid and amyloid deposits in Gerstmann-Straussler-Scheinker disease, Indiana kindred
18. Congophilic angiopathy of the brain: A clinical and pathological report on two siblings
19. Familial cerebellar ataxia with cerebrovascular amyloid
20. The presubicular region in Alzheimer's disease: Topography of amyloid deposits and neurofibrillary changes
21. Beta-protein amyloid is widely distributed in the central nervous system of patients with Alzheimer's disease
22. Diffuse, lake-like amyloid-beta deposits in the parvopyramidal layer of the presubiculum in Alzheimer disease
23. The abnormal phosphorylation of tau-protein at ser-202 in Alzheimer disease recapitulates phosphorylation during development
24. Early phosphorylation of tau in Alzheimer's disease occurs at Ser-202 and is preferentially located within neurites
25. An extensive network of PHF-τ-rich dystrophic neurites permeates neocortex and nearly all neuritic and diffuse amyloid praques in Alzheimer disease
26. Secondary deposition of beta amyloid within extracellular neurofibrillary tangles in Alzheimer-type dementia
27. Neuropathological stageing of Alzheimer-related changes
28. Sequential phosphorylation of tau by glycogen synthase kinase-3 beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation
29. Relationship between non-fibrillary amyloid precursors and cell processes in the cortical neuropil of Alzheimer patients
30. Early association of reactive astrocytes with senile plaques in Alzheimer's disease
31. Translating cell biology into therapeutic advances in Alzheimer's disease
32. Cerebral amyloid angiopathy - Amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease
33. Furin mediates enhanced production of fibrillogenic ABri peptides in familial British dementia
34. Region specific expression of furin mRNA in the rat brain
35. Deposition of beta/A4 protein along neuronal plasma membranes in diffuse senile plaques
36. Deposition of amyloid beta protein in non-Alzheimer dementias: Evidence for a neuronal origin of parenchymal deposits of beta protein in neurodegenerative disease
37. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid
38. Production of the Alzheimer amyloid beta protein by normal proteolytic processing
39. Alzheimer's soluble amyloid beta is a normal component of human urine
40. Tau protein pathology in neurodegeneratire diseases
41. A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1
42. Variant Alzheimer's disease with spastic paraparesis and "cotton wool" plaques is caused by PS-1 mutations which lead to exceptionally high Aβ concentrations
43. Leukoencephalopathy in diffuse hemorrhagic cerebral amyloid angiopathy
44. Immunohistochemical study of cerebral amyloid angiopathy. III. Widespread Alzheimer A4 peptide in cerebral microvessel walls colocalizes with gamma trace in patients with leukoencephalopathy